| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.44B | 18.01B | 19.86B | 22.20B | 17.73B |
| Gross Profit | 2.26B | 2.40B | 2.60B | 2.40B | 2.04B |
| EBITDA | 881.33M | 785.73M | 882.88M | 856.65M | 770.47M |
| Net Income | 13.36M | 206.49M | 326.25M | 334.02M | 312.37M |
Balance Sheet | |||||
| Total Assets | 8.27B | 9.26B | 9.48B | 9.84B | 9.56B |
| Cash, Cash Equivalents and Short-Term Investments | 1.09B | 1.09B | 1.11B | 1.42B | 1.39B |
| Total Debt | 2.28B | 2.28B | 2.31B | 2.60B | 2.34B |
| Total Liabilities | 5.90B | 6.09B | 6.30B | 6.78B | 6.59B |
| Stockholders Equity | 2.26B | 3.07B | 3.09B | 2.98B | 2.91B |
Cash Flow | |||||
| Free Cash Flow | 475.45M | 367.73M | 491.67M | 427.46M | 257.42M |
| Operating Cash Flow | 684.10M | 582.03M | 722.02M | 656.90M | 451.77M |
| Investing Cash Flow | 344.92M | -338.14M | -525.29M | -531.52M | -867.43M |
| Financing Cash Flow | -1.11B | -180.89M | -472.75M | -100.16M | 21.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £2.86B | 21.39 | 9.72% | 5.64% | 49.70% | -5.56% | |
69 Neutral | £4.22B | -23.64 | -4.05% | 8.77% | 57.55% | -54.80% | |
66 Neutral | £5.26B | 393.61 | 0.55% | 4.43% | -14.26% | -79.14% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | £66.21M | 12.49 | 6.02% | 6.59% | -5.21% | -33.93% | |
64 Neutral | £3.68B | 20.19 | 9.33% | 14.05% | 36.10% | ― | |
63 Neutral | £705.65M | 2.77 | 40.22% | 10.49% | ― | ― |